The aim of the current study was to delineate the gene expression profile of three CSCs related genes, LGR5, HES1 and ATOH1, among young Egyptian rectal cancer patients, and investigate possible association between these genes’ expression and clinical outcome, including response to neoadjuvant chemoradiotherapy. This evidence concerns the gene HES1 and rectal cancer.